Gene, Cell, & RNA Therapy Landscape Report

The Gene, Cell, & RNA Therapy Landscape report, created in partnership with Informa Pharma Intelligence, is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Q2 2021: New Gene Therapy Approved in Japan

Highlights from the report include: One new gene therapy approval in Japan, and approval in additional countries/regions of three previously-approved gene therapies, oncology remaining the most active therapeutic area of research, a marked increase in financing for start-ups, overall dealmaking volume increasing from a year ago.

Report Archive

Q1 2021

The data show unequivocally that gene, cell, and RNA therapies continue to grow rapidly with nearly 3,500 therapies in preclinical and clinical development throughout the world.

Q2 2021

Highlights in the second quarter of 2021 include the approval of a new gene therapy in Japan, the expansion of gene therapy approvals to three new countries, and more!

2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.